Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
1 competitor in Amyotrophic Lateral Sclerosis (ALS)
View Full LandscapeTarget Indication
Amyotrophic Lateral Sclerosis (ALS)
Clinical Trial
NCT01492686Last updated: 7/21/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.